These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10919207)

  • 1. [The precaution principle and blood transfusion].
    Sicard D
    Transfus Clin Biol; 2000 Jun; 7(3):220-7. PubMed ID: 10919207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Theoretical risk management and legitimacy of the precautionary principle in medicine. Look back at HIV contamination through blood transfusion in France, twenty years ago].
    Moutel G; Hergon E; Duchange N; Bellier L; Rouger P; Hervé C
    Transfus Clin Biol; 2005 Feb; 12(1):38-44. PubMed ID: 15814292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion safety: emergent or hypothetical risks].
    Hervé P
    Transfus Clin Biol; 2000 Feb; 7(1):30-8. PubMed ID: 10730344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV and blood transfusions: focus on seroconversion.
    Busch MP
    Vox Sang; 1994; 67 Suppl 3():13-8. PubMed ID: 7975476
    [No Abstract]   [Full Text] [Related]  

  • 5. The application of the precautionary principle to the blood system: the Canadian blood system's vCJD donor deferral policy.
    Wilson K; Wilson M; Hébert PC; Graham I
    Transfus Med Rev; 2003 Apr; 17(2):89-94. PubMed ID: 12733102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of the nucleic acids of hepatitis B and C viruses and human immunodeficiency virus for the biological screening of blood donations. Viral Hepatitis and Retrovirus Working Groups and Subgroup for Molecular Biology Applied to Transfusion Virology of the French Blood Transfusion Society].
    Laperche S
    Transfus Clin Biol; 1998 Apr; 5(2):139-46. PubMed ID: 9618839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Economic analysis versus the principle of guaranteed safety in blood transfusion].
    Moatti JP; Loubière S; Rotily M
    Transfus Clin Biol; 2000 Jun; 7(3):228-35. PubMed ID: 10919208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening tests combined with p24 antigen and anti-HIV antibodies in early detection of HIV-1].
    Laperche S; Maniez-Montreuil M; Couroucé AM
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():18s-24s. PubMed ID: 10919219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Precautionary Principle and the Tolerability of Blood Transfusion Risks.
    Kramer K; Zaaijer HL; Verweij MF
    Am J Bioeth; 2017 Mar; 17(3):32-43. PubMed ID: 28207362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk management in transfusion after the HIV blood contamination crisis in France: the impact of the precautionary principle.
    Hergon E; Moutel G; Duchange N; Bellier L; Rouger P; Hervé C
    Transfus Med Rev; 2005 Oct; 19(4):273-80. PubMed ID: 16214016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
    Weusten JJ; van Drimmelen HA; Lelie PN
    Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of p24 antigen among a cohort of HIV antibody negative blood donors in Sokoto, North Western Nigeria--the question of safety of blood transfusion in Nigeria.
    Osaro E; Mohammed N; Zama I; Yakubu A; Dorcas I; Festus A; Kwaifa I; Sani I
    Pan Afr Med J; 2014; 18():174. PubMed ID: 25419301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
    Dogbe EE; Arthur F
    Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-benefit analysis of screening strategies by human immunodeficiency virus in French blood donors].
    Djossou F; Salmi LR; Lawson-Ayayi S; Huët C; Perez P; Mathoulin-Pélissier S; Salamon R
    Transfus Clin Biol; 1999 Jun; 6(3):180-8. PubMed ID: 10422211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening for viral genomes in blood transfusion].
    Coste J
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():11s-17s. PubMed ID: 10919218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant Creutzfeldt-Jakob disease (vCJD). Precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion.
    Wkly Epidemiol Rec; 2000 Nov; 75(47):377-9. PubMed ID: 11144617
    [No Abstract]   [Full Text] [Related]  

  • 17. [Risk of HIV-1 or 2 infection associated with transfusion in Benin].
    Zohoun A; Lafia E; Houinato D; Anagonou S
    Bull Soc Pathol Exot; 2004 Nov; 97(4):261-4. PubMed ID: 17304747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The success of precaution? Managing the risk of transfusion transmission of variant Creutzfeldt-Jakob disease.
    Wilson K; Ricketts MN
    Transfusion; 2004 Oct; 44(10):1475-8. PubMed ID: 15383021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balancing evidence and public opinion in health technology assessments: the case of leukoreduction.
    Cleemput I; Leys M; Ramaekers D; Bonneux L
    Int J Technol Assess Health Care; 2006; 22(4):403-7. PubMed ID: 16984672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor selection: the exclusion of high risk donors?
    van den Burg PJ; Vrielink H; Reesink HW
    Vox Sang; 1998; 74 Suppl 2():499-502. PubMed ID: 9704489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.